Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1open access
- Authors
- Hong, Wei; Kim, Alexander Y.; Ky, Sokun; Rakowski, Carrie; Seo, Sang-Beom; Chakravarti, Debabrata; Atchison, Michael; Blobel, Gerd A.
- Issue Date
- Jun-2002
- Publisher
- AMER SOC MICROBIOLOGY
- Citation
- MOLECULAR AND CELLULAR BIOLOGY, v.22, no.11, pp 3729 - 3743
- Pages
- 15
- Journal Title
- MOLECULAR AND CELLULAR BIOLOGY
- Volume
- 22
- Number
- 11
- Start Page
- 3729
- End Page
- 3743
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/57466
- DOI
- 10.1128/MCB.22.11.3729-3743.2002
- ISSN
- 0270-7306
1098-5549
- Abstract
- Aberrant expression of PU.1 inhibits erythroid cell differentiation and contributes to the formation of murine erythroleukemias (MEL). The molecular mechanism by which this occurs is poorly understood. Here we show that PU.1 specifically and efficiently inhibits CBP-mediated acetylation of several nuclear proteins, including the hematopoietic transcription factors GATA-1, NF-E2, and erythroid Kruppel-like factor. In addition, PU.1 blocks acetylation of histones and interferes with acetylation-dependent transcriptional events. CBP acetyltransferase activity increases during MEL cell differentiation as PU.1 levels decline and is inhibited by sustained PU.1 expression. Finally, PU.1 inhibits the differentiation-associated increase in histone acetylation at an erythroid-specific gene locus in vivo. Together, these findings suggest that aberrant expression of PU.1 and possibly other members of the Ets family of oncoproteins subverts normal cellular differentiation in part by inhibiting the acetylation of critical nuclear factors involved in balancing cellular proliferation and maturation.
- Files in This Item
-
- Appears in
Collections - College of Natural Sciences > Department of Life Science > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/57466)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.